Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jan 14, 2019; 25(2): 258-268
Published online Jan 14, 2019. doi: 10.3748/wjg.v25.i2.258
Table 1 Characteristics of patients who underwent R0 resection for gastric cancer n (%)
CharacteristicAll patients (n = 4173)2009-2013 (n = 2219)2014-2016 (n = 1954)P-value
Mean age, yr0.148
< 652701 (64.7)1414 (63.7)1287 (65.9)
≥ 651472 (35.3)805 (36.3)667 (34.1)
Sex0.002
Male3083 (73.9)1683 (75.8)1400 (71.6)
Female1090 (26.1)536 (24.2)554 (28.4)
Mean BMI, kg/m2 (SD)22.3 (5.2)22.0 (3.1)22.6 (3.7)< 0.001
History of abdominal surgery0.436
No3543 (84.9)1875 (84.5)1668 (85.4)
Yes630 (15.1)344 (15.5)286 (14.6)
Tumor site< 0.001
Upper1136 (27.2)590 (26.6)546 (27.9)
Middle892 (21.4)383 (17.3)509 (26.0)
Lower1654 (39.6)958 (43.2)696 (35.6)
≥ 2 areas491 (11.8)288 (13.0)203 (10.4)
Malnourished0.277
No3730 (89.4)1919 (88.9)1811 (89.9))
Yes443 (10.6)240 (11.1)203 (10.1)
Mean tumor size, cm (SD)4.4 (2.6)4.6 (2.6)4.0 (2.7)< 0.001
AJCC-TNM stage, 8th edition< 0.001
I1158 (27.7)598 (26.9)560 (28.7)
II1052 (25.2)487 (21.9)565 (28.9)
III1963 (47.0)1134 (51.1)829 (42.4)
Comorbidities0.112
No2876 (68.9)1553 (70.0)1323 (67.7)
Yes1297 (31.1)666 (30.0)631 (32.3)
HB, g/dL0.317
≥ 903718 (89.1)1967 (88.6)1751 (89.6)
< 90455 (10.9)252 (11.4)203 (10.4)
ASA0.641
I-II4000 (95.9)2130 (96.0)1870 (95.7)
III-IV173 (4.1)89 (4.0)84 (4.3)
Operation method< 0.001
Open670 (16.1)469 (21.1)201 (10.3)
Laparoscopic3503 (83.9)1750 (78.9)1753 (89.7)
Type of resection0.235
Subtotal gastrectomy1873 (44.9)1015 (45.7)858 (43.9)
Total gastrectomy2300 (55.1)1204 (54.3)1096 (56.1)
Type of reconstruction< 0.001
Billroth I1100 (26.4)782 (35.2)318 (16.3)
Billroth II540 (12.9)160 (7.2)380 (19.4)
Roux-en-Y2468 (59.1)1225 (55.2)1243 (63.6)
Other65 (1.6)52 (2.3)13 (0.7)
Mean surgical duration, min (SD)184.7 (67.6)191.3 (67.8)177.1 (66.7)< 0.001
Mean intraoperative blood loss, mL (SD)94.7 (256.8)115.0 (335.3)71.5 (108.6)< 0.001
Mean length of stay, d (SD)13.5 (7.8)13.5 (7.4)13.4 (8.2)0.296
AL83 (2.0)37 (1.7)46 (2.4)0.113
Table 2 Postoperative mortality, morbidity, and treatment modality among patients with anastomotic leakage after radical gastrectomy before (2009-2013) and after (2014-2016) implementation of the abdominal negative pressure lavage-drainage system n (%)
Postoperative conditionAll patients (n = 83)2009-2013 (n = 37)2014-2016 (n = 46)P-value
Death7 (8.4)6 (16.2)1 (2.2)0.041
Time of occurrence of AL, d (mean)5.65.45.70.738
Other complication
Pneumonia41 (49.3)16 (43.2)25 (54.3)0.315
Abdominal bleeding8 (9.6)7 (18.9)1 (2.2)0.020
Pancreatic fistula3 (3.6)3 (8.1)0 (0)0.085
Chylous leak4 (4.8)3 (8.1)1 (2.2)0.319
Anastomotic bleeding2 (2.4)2 (5.4)0 (0)0.196
Wound infection4 (4.8)2 (5.4)2 (4.3)> 0.999
ARF&RI2 (2.4)2 (5.4)0 (0)0.196
Cardiac event2 (2.4)1 (2.7)1 (2.2)> 0.999
HF and hypohepatia2 (2.4)1 (2.7)1 (2.2)> 0.999
Treatment
No invasive58 (69.9)18 (48.6)40 (87.0)< 0.001
CT-guided puncture drainage16 (19.3)11 (29.7)5 (10.9)0.030
endoscopy3 (3.6)3 (8.1)0 (0)0.085
Reoperation6 (7.2)5 (13.5)1 (2.2)0.084
Length of stay, d (mean)30.231.628.40.458
Table 3 Risk factors predictive of anastomotic leakage after radical gastrectomy
FactorMultivariate analysis results
OR (95%CI)P-value
Age, yr
< 65Reference0.006
≥ 651.886 (1.195-2.975)
Malnourished
NoReference0.005
Yes2.194 (1.267-3.797)
Comorbidities
NoReference0.171
Yes1.377 (0.871-2.178)
HB, g/dL
≥ 90Reference0.221
< 901.441 (0.803-2.586)
Type of resection
Subtotal gastrectomyReference0.069
Total gastrectomy1.534 (0.967-2.434)
Table 4 Risk factors predictive of failure-to-rescue after anastomotic leakage with radical gastrectomy for gastric cancer
FactorUnivariate analysis
OR (95%CI)P-value
ANPLDS therapy
NoReference0.040
Yes0.103 (0.012-0.898)
Age, yr
< 65Reference0.532
≥ 650.607 (0.127-2.900)
Sex
FemaleReference0.998
Male/
BMI, kg/m2
< 25Reference0.773
≥ 251.289 (0.230-7.219)
History of abdominal surgery
NoReference0.849
Yes0.808 (0.090-7.286)
Tumor site
UpperReference0.935
Middle/0.998
Lower0.697 (0.106-4.578)0.707
≥ 2 areas1.394 (0.203-9.585)0.736
Malnourished
NoReference0.710
Yes1.388 (0.247-7.802)
Tumor size, cm
≤ 5Reference0.700
> 51.361 (0.283-6.535)
AJCC-TNM stage, 8th edition
I-IIReference0.115
III5.692 (0.654-49.570)
Comorbidities
NoReference0.448
Yes1.833 (0.383-8.765)
HB, g/dL
≥ 90Reference0.728
< 900.678 (0.076-6.063)
ASA
I-IIReference0.567
III-IV1.944 (0.200-18.920)
Operation method
OpenReference0.073
Laparoscopic0.226 (0.044-1.149)
Type of resection
Subtotal gastrectomyReference0.763
Total gastrectomy1.300 (0.236-7.166)
Type of reconstruction
Billroth IReference0.997
Billroth II0.817 (0.148-4.520)0.817
Roux-en-Y/> 0.999
Other/0.999
Surgical duration, min (SD)
> 180Reference0.138
≤ 1803.629 (0.661-19.914)
Intraoperative blood loss, ml
> 50Reference0.997
≤ 50/